MEMORANDUM OPINION
This matter comes before the Court on defendant’s motion to dismiss, or in the alternative, for summary judgment, plaintiffs opposition, and the reply thereto. Upon consideration of the filings, the entire record herein and the relevant law, the Court will deny defеndant’s motion to dismiss and grant defendant’s motion for summary judgment.
I. Procedural Posture
This case originated when plaintiff Judicial Watch, Inc. (“Judicial Watch”), filed a request with defendant, United States Food and Drug Administration (“FDA”) on August 22, 2006, under the Freedom of Information Act (“FOIA”) seeking “any or all communicаtions and/or correspondence between the FDA and Senator Hillary Rodham Clinton, ... [and/or] any agent and representative of Senator Hillary Rod-ham Clinton, and/or the Office of Senator Hillary Rodham Clinton regarding ‘.75 le-vonorgestrel,’ also sold undеr the trade name ‘Plan B.’ ” (“Clinton FOIA request”) (See Plaintiffs Amended Complaint (“Am. Compl.”)). Not having received any documents, plaintiff filed the instant suit on March 21, 2007. On April 18 and April 20, 2007, plaintiff filed two additional FOIA requests with defendant seeking records or documents pertaining to communicаtions between FDA and Senators Patty Murray and Michael Enzi, respectively, involving Plan B. (“Murray FOIA request” and “Enzi FOIA request”) (See Am. Compl.). The additional requests were virtually identical to the Clinton request.
Defendant subsequently filed a motion to dismiss on May 4, 2007, or in the alternative, for summary judgment. On July 6, 2007, this Court granted plaintiff leave to file an amended complaint to include *86 claims related to the Murray and Enzi FOIA requests. This Court denied defendant’s motion to dismiss, or in the alternative for summary judgment, as to the original complaint, without prejudice to renewal. Plaintiff re-filed its amended complaint that same day. Defendant then filed a renewed motion to dismiss on July 16, 2007, or in the alternative for summary judgment. (Def.’s Mot. from July 16, 2007). This was followed by a memorandum in opposition filed by plaintiff (see PL’s Mem. from July 30, 2007) and a subsequent reply by defendаnt (see Def.’s Mem. from August 8, 2007).
II. Background
Plaintiff Judicial Watch is a non-profit, educational organization incorporated under the laws of the District of Columbia. (Comply 3). Defendant FDA is an agency of the United States Government. (Id. ¶ 4). On August 22, 2006, plaintiff filed a request with defendant under the FOIA seeking records аnd documents pertaining to communications between FDA and Senator Clinton regarding Plan B. (See “Am. Compl.”). In a letter dated, August 24, 2006, defendant acknowledged receipt of plaintiffs FOIA request. (See id.).
Subsequent to the filing of this action, FDA sent plaintiff records responsive to thе Clinton FOIA request consisting of 28 pages of documents. (See Granger Decl. ¶ 5). On April 18 and April 20, 2007, plaintiff filed two additional requests under the FOIA seeking records and documents pertaining to communications between FDA and Senators Murray and Enzi. (See Am. Compl.). On April 20 and April 23, 2007, defendant sеnt plaintiff letters acknowledging receipt of plaintiffs FOIA requests. (See id.). FDA produced records responsive to plaintiffs Murray and Enzi requests on July 10, 2007. (See Def.’s Mem. from July 16, 2007).
Plaintiff challenges the reasonableness and adequacy of defendant’s search. (See Pl.’s Mem. from July 30, 2007). According to рlaintiff, certain records missing from defendant’s production demonstrate that defendant did not conduct a reasonable search. Plaintiff further contends that declarations submitted by defendant lack sufficient detail to demonstrate the reasonаbleness of defendant’s search.
III. Analysis
A. Defendant’s Motion to Dismiss, or in the Alternative, for Summary Judgment
1. Legal Standard
Pursuant to Federal Rule of Civil Procedure 12(b)(1), the plaintiff bears the burden of establishing that the court has jurisdiction. In turn, the court has an “affirmative obligation to ensure that it is аcting within the scope of its jurisdictional authority,”
see Grand Lodge of Fraternal Order of Police v. Ashcroft,
On a motion to dismiss for failure to state a claim upon which relief can be granted pursuant to Rule 12(b)(6), this Court will dismiss a claim if the plaintiff fails to plead “enough facts to state a claim fоr relief that is plausible on its face.”
Bell Atlantic Corp. v. Twombly,
— U.S. -,
Under Federal Rule of Civil Procedure 56(c), a court must grant summary judgment when the evidence in the record demonstrates that there are no disputed issues of mаterial fact and that the moving party is entitled to judgment on the undisputed facts as a matter of law. Fed. R.Civ.P. 56(c). A genuine issue of material fact exists if the evidence, when viewed in light most favorable to the non-moving party, “is such that a reasonable jury could return a verdict for the nonmoving party.”
Anderson v. Liberty Lobby, Inc.,
For an agency to prevail on a motion for summary judgment in a FOIA action, it must prove that no genuine issue of material fact exists, viewing the facts in the light most favorable to the requester.
Weisberg v. U.S. Dep’t of Justice,
2. Mootness
Defendant FDA argues that plaintiffs claim is moot because FDA provided the requested records. Additionаlly, defendant argues that plaintiff does not state any claim for which relief may be granted. Federal courts may decide only “actual, ongoing controversies.”
Clarke v. United States,
In FOIA cases, а claim typically becomes moot once all documents are released to the requester.
See Crooker v. U.S. State Dep’t,
3. Reasonableness and Adequacy of Defendant’s Search
To meet its summary judgment burden, “the agency must demonstrate that it has conducted a search reasonably calculated to uncover all relevant documents.”
Steinberg v. U.S. Dep’t of Justice,
Plaintiff argues that missing records demonstrate that FDA did not conduct a reasonable search for the requested documents. Specifically, plaintiff asserts that it is “unreasonable to think” that there were no notes or written information from FDA’s briefing of three senators.
(See
Pl.’s Mem. from July 30, 2007). Plaintiff also relies on public statеments made by Senators Clinton and Murray that suggest, according to plaintiff, that it is “highly unlikely” that FDA does not have additional records responsive to plaintiffs request.
(See id.).
The D.C. Circuit has made clear that a FOIA requestor who challenges the reasonableness оf a search “because the agency did not find responsive documents that [the requester] claims must exist” cannot sustain that challenge when he “provides no proof that these documents exist and [offers only] his own conviction that [an event] wаs of such importance that records must have been created.”
Oglesby,
*89 Plaintiff also challenges the reasonableness of FDA’s search on grounds that declarations submitted by FDA are insufficiently detailed. To support its claim, plaintiff asserts that the declarations lack descriptions of the search terms used or the types of searches performed. (See Pl.’s Mem. from July 30, 2007). Plaintiff further asserts that the declarations fail to describe how the search was actually conducted and what records were found as a result of the sеarch.
An agency may use reasonably detailed, non-conclusory affidavits to demonstrate that it conducted a reasonable search in accordance with the FOIA.
See Ground Saucer Watch, Inc. v. CIA,
In the instant matter, FDA searched each office identified as likely to have responsive documents and provided detailed information about the types of searches conducted in those offices. (See July Granger Decl. ¶ 12). In response to plaintiffs assertions, FDA provided plaintiff and this Court with supplemental declarations detailing its general search methodology and the search for records conducted in this case. 1 Each of the suрplemental declarations further contain detailed descriptions of the files that were searched and the search terms that were used for the searches. (See Supp. Gran-ger Decl. ¶¶ 4-6; Supp. Mungo Decl. ¶¶ 4-5; Supp. Palmer Decl. ¶¶ 6-8; Supp. Schiftеr Decl. ¶ 6-8.)
This Court is satisfied that FDA has acted in good faith toward the plaintiff and this Court. In light of the original and supplemental declarations submitted by the defendant, it is clear to this Court that FDA satisfied its obligation under the FOIA to provide an adequate and reasonаble search.
III. CONCLUSION
For the foregoing reasons, this Court concludes that FDA has met its summary judgment burden of demonstrating its search conducted in response to plaintiffs FOIA requests was reasonably conducted and thus adequate. Accordingly, this Court will deny defendant’s motion to dismiss and grant defendant’s motion [25] for summary judgment.
A separate Order accompanies this Memorandum Opinion.
Notes
. Plaintiff filed no motion for leave to file a surreply challenging defendant's supplemental declarations.
